News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,340 Results
Type
Article (14914)
Company Profile (299)
Press Release (267121)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80009)
Career Advice (163)
Deals (13384)
Drug Delivery (39)
Drug Development (50709)
Employer Resources (31)
FDA (5845)
Job Trends (5172)
News (145321)
Policy (10080)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (921)
Accelerated approval (19)
Adcomms (14)
Allergies (85)
Alliances (21777)
ALS (126)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (244)
Approvals (6041)
Artificial intelligence (267)
Autoimmune disease (119)
Automation (9)
Bankruptcy (105)
Best Places to Work (4562)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (348)
Cancer (3163)
Cardiovascular disease (239)
Career advice (148)
Career pathing (8)
CAR-T (224)
CDC (5)
Cell therapy (577)
Cervical cancer (14)
Clinical research (43724)
Collaboration (1168)
Company closure (2)
Compensation (603)
Complete response letters (41)
COVID-19 (1101)
CRISPR (88)
C-suite (565)
Cystic fibrosis (112)
Data (4359)
Denatured (15)
Depression (93)
Diabetes (256)
Diagnostics (1389)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (218)
Earnings (31813)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (51737)
Executive appointments (628)
FDA (7613)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (991)
Gene editing (185)
Generative AI (22)
Gene therapy (497)
GLP-1 (507)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6616)
HIV (18)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (194)
Immuno-oncology (43)
Indications (71)
Infectious disease (1211)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (169)
Interviews (18)
IPO (7352)
IRA (13)
Job creations (868)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (23)
Layoffs (243)
Leadership (10)
Legal (1402)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (251)
Machine learning (24)
Management (7)
Manufacturing (380)
MASH (132)
Medical device (2666)
Medtech (2675)
Mergers & acquisitions (6664)
Metabolic disorders (733)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (1965)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (867)
Now hiring (31)
Obesity (333)
Opinion (125)
Ovarian cancer (132)
Pain (103)
Pancreatic cancer (165)
Parkinson's disease (232)
Partnered (12)
Patents (306)
Patient recruitment (345)
Peanut (44)
People (26719)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15492)
Phase 2 (20316)
Phase 3 (12831)
Pipeline (3355)
Policy (91)
Postmarket research (853)
Preclinical (6543)
Press Release (30)
Prostate cancer (147)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (661)
Real estate (1449)
Recruiting (12)
Regulatory (9930)
Reports (19)
Research institute (974)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (125)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (340)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Last 7 days (315)
Last 30 days (1105)
Last 365 days (17757)
2026 (1967)
2025 (18103)
2024 (20562)
2023 (22440)
2022 (26879)
2021 (27861)
2020 (23401)
2019 (16241)
2018 (11754)
2017 (13761)
2016 (11855)
2015 (14368)
2014 (10407)
2013 (7504)
2012 (7550)
2011 (7636)
2010 (7440)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18276)
Australia (3117)
California (7141)
Canada (1857)
China (784)
Colorado (249)
Connecticut (255)
Delaware (237)
Europe (39214)
Florida (912)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (398)
India (36)
Indiana (162)
Iowa (8)
Japan (228)
Kansas (80)
Kentucky (11)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5629)
Michigan (141)
Minnesota (250)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (9)
Nevada (33)
New Hampshire (21)
New Jersey (1658)
New Mexico (13)
New York (1775)
North Carolina (837)
North Dakota (6)
Northern California (3516)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1287)
Puerto Rico (9)
Rhode Island (26)
South America (217)
South Carolina (9)
Southern California (2831)
Tennessee (40)
Texas (921)
United States (23573)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
282,340 Results for "neogene therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
January 29, 2026
·
3 min read
Press Releases
Neogen® Announces Two Senior Leadership Appointments
January 5, 2026
·
1 min read
Press Releases
Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education
September 25, 2025
·
1 min read
BioMidwest
Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes
Neogen® Corporation announced the launch of the new Neogen Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium.
April 30, 2024
·
3 min read
Press Releases
Neogen Announces Third-Quarter Earnings Release Date
March 21, 2025
·
1 min read
Business
Neogen Announces Third-Quarter 2024 Results
Neogen Corporation (NASDAQ: NEOG) announced today the results of the third quarter ended February 29, 2024.
April 9, 2024
·
15 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
BioMidwest
Neogen® to Participate in the Bank of America 2024 Health Care Conference
Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Bank of America 2024 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 15, 2024.
May 8, 2024
·
1 min read
BioMidwest
Neogen® to Participate in the 44th Annual William Blair Growth Stock Conference
Neogen announced today that the Company will participate in the 44th Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 4, 2024.
May 30, 2024
·
1 min read
Press Releases
Neogen® To Participate in Upcoming January 2025 Investor Conferences
January 8, 2025
·
1 min read
1 of 28,234
Next
